Health CanadaType I
PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg: NDMA and NNORT impurity
Published: August 16, 2023Recall ID: 74145Category: generalCountry: Canada
Reason for Recall / Hazard
Contamination
Product Description & Identification
Continue taking your medication.Not treating a condition may pose a greater health risk than potential nitrosamine exposure.Contact your health care provider:to discuss treatment options if you're using a recalled productif you have taken a recalled product and are concerned about your healthAsk your pharmacist if you're not sure if the product you're taking has been recalled.
Affected Products
PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg
Additional Source Details
| Field | Value |
|---|---|
| N I D | 74145 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/pms-amitriptyline-10-mg-25-mg-and-50-mg-ndma-and-nnort-impurity |
| Issue | Contamination |
| Title | PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg: NDMA and NNORT impurity |
| Product | PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2023-08-16 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Continue taking your medication.Not treating a condition may pose a greater health risk than potential nitrosamine exposure.Contact your health care provider:to discuss treatment options if you're using a recalled productif you have taken a recalled product and are concerned about your healthAsk your pharmacist if you're not sure if the product you're taking has been recalled. |